WELL Health Technologies Corp. Announces $12.5 Million Bought Deal Common Share Financing

NEXT STORY
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19
PREV STORY
Global Life Science Instrumentation Industry (2019 to 2025) – Increased Demand for Personalized Medicine Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Plans to Submit Marketing Authorization Application for Surufatinib Following Scientific Advice from EMA’s CHMP

author_avatar
NASDAQ Market News

Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19

author_avatar
NASDAQ Market News

Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes

 Sanofi Receives FDA Approval of Soliqua(TM) 100/33 for the Treatment of Adults with Type ...

author_avatar
NASDAQ Market News